We analyzed formalin-fixed paraffin-embedded (FFPE) tumor samples collected before receipt of checkpoint blockade (defined as the first line of therapy in which a patient received a PD-1/PD-L1 agent) from a total of 393 patients with advanced NSCLC across nine cancer centers (Table 1 and Fig. 1a). This evidence concerns the gene CD274 and neoplasm.